STOCK TITAN

Emergent BioSolutions (EBS) director granted RSUs and stock options in annual award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Emergent BioSolutions director Neal Franklin Fowler received new equity awards as part of his annual board compensation. He was granted 25,344 restricted stock units, each representing one share of common stock that will vest the day before the one-year anniversary of the grant, if he remains on the board.

He also received stock options for 11,296 shares at an exercise price of $7.99 per share, vesting on the same schedule. After these awards, he directly holds 160,847 shares of common stock, plus the newly granted options. These are compensation grants, not open‑market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Fowler Neal Franklin
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 11,296 $0.00 --
Grant/Award Common Stock 25,344 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 11,296 shares (Direct, null); Common Stock — 160,847 shares (Direct, null)
Footnotes (1)
  1. Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
RSU grant 25,344 RSUs Annual non-employee director grant for board and committee service
Option grant size 11,296 options Stock options granted for board and committee service
Option exercise price $7.99 per share Exercise price for newly granted stock options
Shares held after grant 160,847 shares Common stock directly held by Neal Fowler after the RSU grant
Underlying shares per option 1 share per option Each option covers one share of common stock
restricted stock units ("RSUs") financial
"Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Incentive Plan financial
"granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
Annual Grant Vesting Date financial
"The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date")"
Black-Scholes value financial
"dividing by the Black-Scholes value of a single option calculated as of the date of the grant"
stock options financial
"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fowler Neal Franklin

(Last)(First)(Middle)
300 PROFESSIONAL DRIVE

(Street)
GAITHERSBURG MARYLAND 20879

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Emergent BioSolutions Inc. [ EBS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/30/2026A25,344(1)A$0160,847D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$7.9904/30/2026A11,296 (2)04/30/2033Common Stock11,296(3)$011,296D
Explanation of Responses:
1. Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
2. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
3. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
Remarks:
/s/ Richard S. Lindahl, Attorney-in-fact05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Emergent BioSolutions (EBS) director Neal Fowler report?

Director Neal Fowler reported receiving equity compensation, not market trades. He was granted 25,344 restricted stock units and 11,296 stock options as part of his non-employee director pay for board and committee service, all subject to future vesting conditions tied to continued board membership.

How many Emergent BioSolutions (EBS) RSUs were granted to Neal Fowler and when do they vest?

Neal Fowler was granted 25,344 restricted stock units. Each RSU converts into one share of Emergent BioSolutions common stock. The entire grant is scheduled to vest on the day prior to the one-year anniversary of the grant date, assuming he remains on the company’s board through that date.

What are the terms of Neal Fowler’s new stock options at Emergent BioSolutions (EBS)?

Fowler received stock options for 11,296 shares of Emergent BioSolutions common stock at a $7.99 exercise price. These options were granted under the company’s Stock Incentive Plan and will vest on the same one-year schedule as the RSUs, conditional on continued board service.

How many Emergent BioSolutions (EBS) shares does Neal Fowler own after these grants?

Following the equity awards, Neal Fowler directly holds 160,847 shares of Emergent BioSolutions common stock. This figure reflects his position after receiving the 25,344 restricted stock units, which are subject to vesting, in addition to his preexisting share ownership as a director.

How were the number of stock options for Emergent BioSolutions (EBS) director Neal Fowler determined?

The option grant size was calculated under the company’s Stock Incentive Plan. It was based on 25% of the total non-employee director compensation value, divided by the Black-Scholes value of a single option as of the grant date, yielding 11,296 options for Fowler.

Are Neal Fowler’s Emergent BioSolutions (EBS) equity awards tied to his continued board service?

Yes. Both the 25,344 restricted stock units and the 11,296 stock options vest on the day before the one-year anniversary of the grant date only if Neal Fowler remains a member of Emergent BioSolutions’ board of directors through that Annual Grant Vesting Date.